Browsing Category
Healthcare Industry News
2778 posts
Evident buys CrestOptics to push deeper into high-speed 3D microscopy
Bain Capital-owned Evident has acquired Rome-based CrestOptics, bringing spinning-disk confocal and super-resolution microscopy technology in-house while preserving CrestOptics’ broader OEM and distribution relationships.
333D (ASX:T3D) rallies 63% as healthcare software growth draws attention
333D Limited surged 62.86% to A$0.057 on October 5 after trading as high as A$0.063 earlier in the session. The move came without a fresh price-sensitive announcement, putting renewed focus on revenue growth, cash, healthcare software and the company's expanding AI strategy.
Telix Pharmaceuticals wins FDA Fast Track for BiPASS as prostate imaging moves before biopsy
Telix Pharmaceuticals Limited has received FDA Fast Track designation for its BiPASS programme, advancing a strategy that combines PSMA-PET and MRI before prostate biopsy as the company prepares a planned US regulatory submission.
Cigna targets $3bn savings as AI reshapes $280bn healthcare platform
The Cigna Group is targeting approximately $3 billion of productivity savings through 2030 while forecasting 10% to 14% annual adjusted earnings-per-share growth and about $50 billion of cumulative operating cash flow.
HCA Healthcare closes CHCP deal as staffing becomes a strategic supply-chain issue
HCA Healthcare has completed its acquisition of The College of Health Care Professions, adding an 8,000-student allied-health education platform to a hospital group increasingly treating workforce development as strategic infrastructure.
Halma (LSE: HLMA) lifts margin outlook to 24% after ÂŁ515m acquisition spree
Halma has increased its FY27 adjusted EBIT margin guidance to 23.5%–24% while maintaining low double-digit organic revenue growth expectations after deploying a record £515 million across six acquisitions.
CVS Group revenue rises 6% as Australian veterinary business reaches ÂŁ79m
CVS Group increased revenue and adjusted earnings in FY26 as its Australian veterinary platform expanded rapidly, but net bank borrowings rose to nearly ÂŁ200 million and cash conversion softened as acquisitions and shareholder returns absorbed capital.
TriSalus gets TriNav Advance FDA clearance after delay weighed on 2026 guidance
TriSalus Life Sciences has received FDA 510(k) clearance for TriNav Advance, enabling Pressure-Enabled Drug Delivery through smaller distal vessels and removing a regulatory delay that had already contributed to a reduction in the company’s 2026 revenue outlook.
Healius (ASX: HLS) to sell Agilex Biolabs to Novotech for A$160m and moves toward net cash
Healius Limited is selling Agilex Biolabs to Novotech for A$160 million, completing another major portfolio exit as the pathology group moves toward a net-cash balance sheet and concentrates capital on Laverty Pathology, Dorevitch Pathology and Queensland Medical Laboratory.
Fangzhou grows revenue to RMB1.82bn as AI strategy expands chronic-care ecosystem
Fangzhou revenue rose 22% to RMB1.82 billion as monthly active users reached 14.7 million and its AI chronic-care strategy continued scaling.